Search All News
Dr. Salvatore discusses her thoughts on the new guidelines, the Lung Cancer Screening Program, and how being a former smoker impacts her work.
Tal Korem, PhD, shares how his lab is using a new decontamination method to prevent blood-borne microbial DNA samples from contamination and improve cancer diagnostic tools.
After being diagnosed in 2001 with chronic lymphocytic leukemia and again in 2018 with lung cancer, Mary Ann is now successfully managing her disease and returning to her calling as an actress.
In this Featured Voice for the HICCC, cancer survivor Oswald Peterson pays tribute to his oncologist, Catherine Shu, MD
- June 27, 2022
A multi-institution team of lung cancer experts have received a new SU2C grant to bring technology-enabled immunotherapy monitoring to under-represented patients.
- June 13, 2022
At ASCO 2022, Dr. Catherine Shu shared updated results from a trial of a combination therapy for patients with EGFR mutated non-small cell lung cancer.
Source:CUIMC NewsroomMay 26, 2022
The comprehensive lung cancer screening program brings together physicians and nurse practitioners from multiple disciplines to provide care for smokers and ex-smokers at high risk for lung cancer.
- March 2, 2022
Columbia University researchers uncovered a signaling pathway in EGFR-mutant lung cancer responsible for driving recurrence and metastases, spreading to the brain.
- November 24, 2020
A physician-researcher in thoracic oncology, Dr. Catherine Shu has a focused interest in improving outcomes for lung cancer patients with resectable disease.